ResearchSafe

Senolytics may reshape ageing mice’s immunity and metabolism – what does that mean for us?

Posted by greg208 in Longevity & Anti-Aging - 1 points, 0 comments.

https://www.nature.com/articles/s43587-026-01130-1

This Nature paper looks at a senolytic cocktail, dasatinib and quercetin, given to 20‑month‑old mice. The authors map changes in immune cells, fibrosis and metabolic markers after treatment. They find that the drug clears a lot of senescent cells and that the mice’s metabolic profile shifts toward a more youthful state.

I’m not surprised that removing “zombie cells” improves health markers; that’s the theory behind these compounds. What’s fresh here is the depth of the profiling – they see shifts in immune tone and fat metabolism that echo some of the results people report when they try D+Q cycles. Still, the mice were dosed over a short, tightly controlled period, and mice metabolism is not a perfect stand‑in for humans. The paper also underplays the potential for off‑target effects – a reminder that senolytics aren’t a silver bullet.

Do you think these metabolic changes translate to a meaningful lifespan extension in humans, or is it more likely just a temporary “boost” that wears off?

Community discussion - research and educational context only. Not medical advice.